Phase III Data Presented at AACR Show Favorable Immune Response for PROVENGE

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：488 / 488
页数：1
相关论文
共 50 条
  • [1] Phase III data on novel, lanthanum carbonate phosphate binder presented at conference
    不详
    DIALYSIS & TRANSPLANTATION, 2003, 32 (06) : 312 - 312
  • [2] ESMO in 2014 Positive Phase-III-Data for the PD-1-Immune-Checkpoint-Inhibitor Nivolumab in advanced Melanoma presented
    Fuerholzer, Ina
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (11)
  • [3] Immune response presents phase II data on psoriasis treatment
    不详
    DRUG NEWS & PERSPECTIVES, 1998, 11 (07) : 441 - 441
  • [4] Phase III data show pharmacia's parecoxib reduces morphine use following surgery
    不详
    DRUG NEWS & PERSPECTIVES, 2001, 14 (03) : 142 - 142
  • [5] Stimulating an immune response through bavituximab in a phase III lung cancer study
    Gerber, David E.
    Shan, Joseph
    Keilholz, Ulrich
    Spigel, David R.
    Horn, Leora
    Heist, Rebecca Suk
    Sanborn, Rachel E.
    Malnwaring, Paul N.
    Belani, Chandra Prakash
    Edelman, Martin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia
    Jain, Shivi
    Gernsheimer, Terry
    Kolodny, Scott
    Bernheisel, Chelsea
    Vredenburg, Michael
    Panch, Sandhya R.
    PLATELETS, 2023, 34 (01)
  • [7] Phase III Data Show Octreotide Reduced Risk of Disease Progression by 66% in Advanced Neuroendocrine Tumor Patients
    不详
    ONCOLOGY-NEW YORK, 2009, 23 (12): : 1104 - 1104
  • [8] Phase III Data in neuroendocrine Tumors show: RAD001 as Monotherapy and in Combination with Sandostatin© LAR© effectively
    Roth, Irene
    VISZERALMEDIZIN, 2010, 26 (04): : 290 - 290
  • [9] Favorable Progression-Free Survival Associated with Immune Bio-Markers Modulated By Pomalidomide in Relapsed/Refractory Multiple Myeloma: An Analysis of Phase III Study
    Prabhala, Rao
    Samur, Mehmet Kemal
    Talluri, Srikanth
    Stekla, Megan
    Yenumula, Chaitanya
    Lopez, Michael A.
    Derebail, Sanika
    Potluri, Lakshmi B.
    Wang, Angela
    Katiki, Aishwarya
    Vangala, Sahan D.
    Haas, Eric
    Buonopane, Michael J.
    Heubeck, Alexander T.
    Fulciniti, Mariateresa
    Szalat, Raphael
    Lazo-Kallanian, Suzan
    Hong, Kevin
    Peluso, Teresa
    Daley, John
    Biyukov, Tsvetan
    Oriol, Albert
    Pierceall, William E.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Thakurta, Anjan
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    BLOOD, 2019, 134
  • [10] Annual Phase III Data on Risankizumab in Crohn's Disease Female Patients achieve endoscopic Response and clinical Remission even in the Maintenance Phase
    不详
    VISCERAL MEDICINE, 2021, 37 (04) : 325 - 325
12345